Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Side Effects & Safety Injection site redness lasting 30-60 minutes, mild Mole/freckle darkening gradual, may complicate skin cancer monitoring Mild fatigue uncommon, on injection days Mild nausea much less than MT-2 No nausea/vomiting at standard doses (MT-1 doesn't significantly activate MC4R) No libido effects limited CNS penetration unlike MT-2 No appetite suppression doesn't affect feeding centers Excessive UV caution false confidence may lead to overexposure mg to Units Conversion On a standard 100-unit insulin syringe, each "unit" equals 0.01 mL (so 100 units = 1 mL)
How to know if your microdose is working Three signals that your current dose is effective: Reduced appetite without nausea : Youre eating less because youre genuinely satisfied, not because you feel sick
In contrast, it is difficult to completely prevent the development of cardiovascular events and CKD by hypoglycaemic therapy alone
A typical protocol involves daily or near-daily subcutaneous injections during an active cycle, followed by a transition to oral NMN supplementation (typically 250 to 500 mg/day) during the maintenance phase
The choice of therapy depends on multiple factors, including medical history, side effect profile, convenience, cost, and personal preferences
However, this is generally not an intended result and is not something seen with standard oral supplementation
